The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update
- 23 April 2004
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Environmental Monitoring
- Vol. 6 (5) , 375-403
- https://doi.org/10.1039/b314329p
Abstract
Until 1990 biokinetic studies of aluminium metabolism and biokinetics in man and other animals had been substantially inhibited by analytical and practical difficulties. Of these, the most important are the difficulties in differentiating between administered aluminium and endogenous aluminium–especially in body fluids and excreta and the problems associated with the contamination of samples with environmental aluminium. As a consequence of these it was not possible to detect small, residual body burdens of the metal following experimental administrations. Consequently, many believed aluminium to be quantitatively excreted within a short time of uptake in all, but renal-failure patients. Nevertheless, residual aluminium deposits in a number of different organs and tissues had been detected in normal subjects using a variety of techniques, including histochemical staining methods. In order to understand the origins and kinetics of such residual aluminium deposits new approaches were required. One approach taken was to employ the radioisotope 67Ga as a surrogate, but this approach has been shown to be flawed–a consequence of the different biological behaviours of aluminium and gallium. A second arose from the availability, in about 1990, of both 26Al–a rare and expensive isotope of aluminium–and accelerator mass spectrometry for the ultra-trace detection of this isotope. Using these techniques the basic features of aluminium biokinetics and bioavailability have been unravelled. It is now clear that some aluminium is retained in the body–most probably within the skeleton, and that some deposits in the brain. However, most aluminium that enters the blood is excreted in urine within a few days or weeks and the gastrointestinal tract provides an effective barrier to aluminium uptake. Aspects of the biokinetics and bioavailability of aluminium are described below.Keywords
This publication has 124 references indexed in Scilit:
- 492 A mortality study of Alzheimer's disease and aluminium exposure through inhalation of McIntyre powder in Cornish Tin MinersNeurobiology of Aging, 1996
- Estimates of dietary exposure to aluminiumFood Additives & Contaminants, 1995
- Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failureJournal of the Neurological Sciences, 1992
- Blood aluminum levels as a function of aluminum intake from drinking waterBulletin of Environmental Contamination and Toxicology, 1991
- Biochemistry of aluminium in relation to the assessment of aluminium exposure in humansEnvironmental Geochemistry and Health, 1990
- Citrate: A major factor in the toxicity of orally administered aluminum compoundsKidney International, 1989
- Demonstration of aluminium in iliac bone: correlation between aluminon and solochrome azurine staining techniques with data on flameless absorption spectrophotometry.Journal of Clinical Pathology, 1988
- Detection and distribution of aluminium in bone.Journal of Clinical Pathology, 1984
- The Prevalence of Bone Aluminum Deposition in Renal Osteodystrophy and Its Relation to the Response to Calcitriol TherapyNew England Journal of Medicine, 1982
- Gastrointestinal Absorption of Aluminum from Aluminum-Containing AntacidsNew England Journal of Medicine, 1977